Precocious puberty - Perspectives on diagnosis and management

Indian Journal of Pediatrics

Volumn 81, Issue 1, 2014, Pages 76-83

  Menon, P S N ^a   Vijayakumar, M ^b  

^a Jaber AL Ahmed Armed Forces Hospital   (Kuwait)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Congenital adrenal hyperplasia; Familial male limited precocious puberty; Gonadotropin releasing hormone analogs; Hypothalamic hamartoma; McCune Albright syndrome; Precocious puberty

Indexed keywords

ANASTROZOLE; BICALUTAMIDE; FULVESTRANT; GONADORELIN; GONADOTROPIN; KETOCONAZOLE; LETROZOLE; LEUPRORELIN; LUTEINIZING HORMONE; SPIRONOLACTONE; TAMOXIFEN; TESTOLACTONE;

BONE AGE; CONFERENCE PAPER; HUMAN; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECOCIOUS PUBERTY; CHILD; FEMALE; MALE; PUBERTY, PRECOCIOUS;

CHILD; FEMALE; HUMANS; MALE; PUBERTY, PRECOCIOUS;

EID: 84898876651     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-013-1177-6     Document Type: Conference Paper

References (52)

1. Garibaldi L, Chemaitilly W. Disorders of pubertal development. In: Kliegman RM, Stanton BF, St. Geme J, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders Elsevier; 2011. pp. 1886-7. Chapter 556.
2. Bajpai A, Menon PSN. Precocious puberty. In: Desai MP, Menon PSN, Bhatia V, eds. Pediatric Endocrine Disorders. 2nd ed. Hyderabad: Orient Longman Ltd; 2008. pp. 217-41.
3. Parent AS, Rasier G, Gerard A, Heger S, Roth C, Mastronardi C, et al. Early onset of puberty: Tracking genetic and environmental factors. Horm Res. 2005;64:41-7. (Pubitemid 41665856)
4. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, Antoniazzi F, et al; ESPE-LWPES GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123:e752-62.
5. Rosenfield R, Cook DW, Radovik S. Puberty and its disorders in female. In: Sperling MA, ed. Pediatric Endocrinology. 3rd ed. Philadelphia: Saunders Elsevier; 2008. pp. 530-600.
6. Bajpai A, Menon PSN. Contemporary issues in precocious puberty. Indian J Endocrinol Metab. 2011;15:S172-9.
7. Dattani MT, Tziaferi V, Hindmarsh PC. Evaluation of disordered puberty. In: Brook CGD, Clayton PE, Brown RS, eds. Brook's Clinical Pediatric Endocrinology. 6th ed. West Sussex: Wiley-Blackwell; 2009. pp. 213-38.
8. Lee PA. Puberty and its disorders. In: Lifshitz F, ed. Pediatric Endocrinology. 4th ed. New York: Marcel Dekker; 2003. pp. 211-38.
9. Brooke CGD. Problems of puberty and adolescence. In: Brooke CGD, Brown RS, eds. Handbook of Clinical and Pediatric Endocrinology. 1st ed. Massachusetts: Blackwell Publishing Inc.; 2008. pp. 59-83.
10. Bajpai A, Sharma J, Kabra M, Gupta A, Menon PSN. Precocious puberty: Clinical and endocrine profile and factors indicating neurogenic precocity in Indian children. J Pediatr Endocrinol Metab. 2002;15:1173-81. (Pubitemid 35153657)
11. Collins MT, Singer FR, Eugster E. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 2012;7:S4. doi:10.1186/1750-1172-7-S1-S4.
12. Jeha GS, Lowenthal ED, Chan WY, Wu SM, Karaviti LP. Variable presentation of precocious puberty associated with the D564G mutation of the LHCGR gene in children with testotoxicosis. J Pediatr. 2006;149:271-4. (Pubitemid 44144488)
13. Fleming NA, de Nanassy J, Lawrence S, Black AY. Juvenile granulosa and theca cell tumor of the ovary as a rare cause of precocious puberty: Case report and review of literature. J Pediatr Adolesc Gynecol. 2010;23:e127-31.
14. Iliev DI, Ranke MB, Wollmann HA. Mixed gonadal dysgenesis and precocious puberty. Horm Res. 2002;58:30-3. (Pubitemid 34914042)
15. Chen QL, Su Z, Li YH, Ma HM, Chen HS, Du ML. Clinical characteristics of adrenocortical tumors in children. J Pediatr Endocrinol Metab. 2011;24:535-41.
16. Nebesio TD, Eugster EA. Current concepts in normal and abnormal puberty. Curr Probl Pediatr Adolesc Health Care. 2007;37:50-72. (Pubitemid 46050447)
17. Raine JE. Puberty. In: Raine JE, Donaldson MDC, eds. Practical Endocrinology and Diabetes in Children. 2nd ed. Massachusetts: Blackwell Publishing; 2006. pp. 69-90.
18. Teilmann G, Pedersen CB, Skakkebaek NE, Jensen TK. Increased risk of precocious puberty in internationally adopted children in Denmark. Pediatrics. 2006;118:e391-9. (Pubitemid 46090509)
19. Worley G, Houlihan CM, Herman-Giddens ME, O' Donnell ME, Conaway M, Stallings VA, et al. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: A cross-sectional survey. Pediatrics. 2002;110:897-902. (Pubitemid 35266147)
20. Striano S, Striano P, Coppola A, Romanelli P. The syndrome gelastic seizures-hypothalamic hamartoma: Severe, potentially reversible encephalopathy. Epilepsia. 2009;50:62-5.
21. Packer RJ, MacDonald T, Vezina G. Central nervous system tumors. Pediatr Clin North Am. 2008;55:121-45. (Pubitemid 351173185)
22. Styne DM. Disorders of puberty. In: Molitch ME, ed. Challenging Cases in Endocrinology. Totowa: Humana Press; 2002. pp. 349-74.
23. Bercaw-Pratt JL, Moorjani TP, Santos XM, Karaviti L, Dietrich JE. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: A case series review. J Pediatr Adolesc Gynecol. 2012;25:e9-13.
24. Nimkarn S, Lin-Su K, New MI. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Pediatr Clin North Am. 2011;58:1281-300.
25. Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: Initial presentation and long-term followup of 20 untreated patients. J Clin Endocrinol Metab. 1999;84:415-23. (Pubitemid 29075662)
26. Adan L, Chemaitilly W, Trivin C, Brauner R. Factors predicting adult height in girls with idiopathic central precocious puberty: Implications for treatment. Clin Endocrinol (Oxf). 2002;56:297-302. (Pubitemid 34310006)
27. Durbin KL, Diaz-Montes T, Loveless MB. Van Wyk and Grumbach syndrome: An unusual case and review of the literature. J Pediatr Adolesc Gynecol. 2011;24:e93-6.
28. Cohee L. Endocrinology. In: Tschudy MM, Arcara KM, eds. The Harriet Lane Handbook. 19th ed. Philadelphia: Elsevier Mosby; 2012. pp. 243-61.
29. Shah KN. The diagnostic and clinical significance of café-au-lait macules. Pediatr Clin North Am. 2010;57:1131-53.
30. Lazar L, Phillip M. Pubertal disorders and bone maturation. Endocrinol Metab Clin North Am. 2012;41:805-25.
31. Dons RF, Wians FH. Endocrine and Metabolic Disorders Clinical Lab Testing Manual. 4th ed. Boca Raton: CRC Press; 2009. pp. 86-91.
32. Bajpai A, Sharma J, Menon PSN. Dynamic endocrine tests. In: Bajpai A, Sharma J, Menon PSN, eds. Practical Pediatric Endocrinology. 1st ed. New Delhi: Jaypee Brothers; 2003. pp. 156-61.
33. Sathasivam A, Garibaldi L, Shapiro S, Godbold J, Rapaport R. Leuprolide stimulation testing for the evaluation of early female sexual maturation. Clin Endocrinol (Oxf). 2010;73:375-81.
34. Sathasivam A, Rosenberg HK, Shapiro S, Wang H, Rapaport R. Pelvic ultrasonography in the evaluation of central precocious puberty: Comparison with leuprolide stimulation test. J Pediatr. 2011;159:490-5.
35. Sharma Y, Bajpai A, Mittal S, Kabra M, Menon PS. Ovarian cysts in young girls with hypothyroidism: Follow-up and effect of treatment. J Pediatr Endocrinol Metab. 2006;19:895-900. (Pubitemid 44354544)
36. Mieszczak J, Houk CP, Lee PA. Management of disordered puberty. In: Brook CGD, Clayton PE, Brown RS, eds. Brook's Clinical Pediatric Endocrinology. 6th ed. West Sussex: Wiley-Blackwell; 2009. pp. 239-49.
37. Curfman AL, Reljanovic SM, McNelis KM, Dong TT, Lewis SA, Jackson LW, et al. Premature thelarche in infants and toddlers: Prevalence, natural history and environmental determinants. J Pediatr Adolesc Gynecol. 2011;24:338-41.
38. Antoniazzi F, Zamboni G. Central precocious puberty: Current treatment options. Paediatr Drugs. 2004;6:211-31. (Pubitemid 39381764)
39. Fuld K, Chi C, Neely EK. A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty. J Pediatr. 2011;159:982-7.
40. Badaru A, Wilson DM, Bachrach LK, Fechner P, Gandrud LM, Durham E, et al. Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty. J Clin Endocrinol Metab. 2006;91:1862-7.
41. Gillis D, Karavani G, Hirsch HJ, Strich D. Time to menarche and final height after histrelin implant treatment for central precocious puberty. J Pediatr. 2013. doi:10.1016/j.jpeds.2013.01.021. Epub ahead of print.
42. Fuqua JS. Treatment and outcomes of precocious puberty: An update. J Clin Endocrinol Metab. 2013;98:2198-207.
43. Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: Impact on adult height, body mass index, bone mineral content, and reproductive function. J Clin Endocrinol Metab. 2008;93:190-5.
44. Kauschansky A, Orvieto R, Yeshaya A, Shterntal B, Naor Z. Insight: Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist: A proposed mechanism and management plan. J Pediatr Adolesc Gynecol. 2011;24:365-7.
45. Bhatia S, Neely EK, Wilson DM. Serum luteinizing hormone rises within minutes after depot leuprolide injection: Implications for monitoring therapy. Pediatrics. 2002;109:E30.
46. Tanaka T, Niimi H, Matsuo N, Fujieda K, Tachibana K, Ohyama K, et al. Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: Evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty. J Clin Endocrinol Metab. 2005;90:1371-6. (Pubitemid 40463991)
47. Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Mengarda F, Pietrobelli A, et al. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. J Clin Endocrinol Metab. 2003;88:1096-101. (Pubitemid 36337761)
48. Javed A, Lteif A, Kumar S. Update on treatment strategies for optimization of final adult height in children with congenital adrenal hyperplasia. Pediatr Endocrinol Rev. 2012;10:164-73.
49. Kreher NC, Pescovitz OH, Delameter P, Tiulpakov A, Hochberg Z. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr. 2006;149:416-20. (Pubitemid 44308423)
50. Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR, et al. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clin Endocrinol (Oxf). 2008;69:93-8. (Pubitemid 351847269)
51. Brunton LL, Blumenthal DK, Buxton ILO, Parker KL. Estrogen and progestins. In: Goodman and Gilman Manual of Pharmacology and Therapeutics. New York: McGraw Hill Medical; 2008. pp. 993-1011.
52. Lenz AM, Shulman D, Eugster EA, Rahhal S, Fuqua JS, Pescovitz OH, et al. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics. 2010;126:e728-33.